Share price of everest organics

Today we come with Everest Organics Share Price which has the ability to give EVERESTO. We can give you 200% surety about the particular stock that can make your portfolio richer. But the question is, why you should believe our option blindly? Of course, you should not. First, see the logic then belive and we are giving you the opportunity to self analyze. Here, we will discuss the top 10 Reasons why Everest Organics Share price Can Double by 2020. To analyze a stock properly both First, let us have a look at the current price of Everest Organics. The stock has closed at Rs. 210 as on 23rd August 2019. Everest Organics Share Price (CMP) Fundamental Analysis of Everest Organics Everest Organics Limited was incorporated in 1993 to carry on the business of manufacturing of bulk drugs viz. Omeprazole, Ciprofloxacin, Dichloroflurobenzene, Benzimadizole, etc. mainly having its factory at Sadasivpet Medak District Hyderabad. The construction activities of this company have started in the year 1994 and the commercial production of the company has started in 1996. During the Year 1995, Everest Organics Limited went into the public issue and the shares of the company have been Over-subscribed by 39.632 times. Everest Organics Limited is headed by Dr. S.K. Srihari Raju who is an NRI and also a Doctor by profession. More About the Company Everest Organics Limited’s Factory has a total area of 32 acres with 23 acres of green belt and 9 acres covered under buildings and roads. A massive...

The Company was incorporated on 19.02.1993 to carry on the business of manufacturing of bulk drugs viz. Omeprazole,Ciprofloxacin, Dichloroflurobenzene, Naproxen, Benzimadizole, etc., having its factory at Sadasivpet, Medak District, Hyderabad. The construction activities have started in the year 1994 and the commercial production of the company has started in 1996. Section 170 Register of Directors KMP Section 189 MBP 4 View Our Annual Report 2021-2022 Everest Organics Annua Report 2020-2021 Everest Organics Annua Report 19-20 EOL Annual Report 2018-19 View Our Annual Report 2008-2009 View Our Annual Report 2009-2010 View Our Annual Report 2010-2011 View Our Annual Report 2011-2012

Everest Organics Limited is an India-based company, which is engaged in manufacturing of active pharmaceutical ingredients (API) and their intermediaries. It is involved in manufacturing of bulk drugs, such as Omeprazole, Ciprofloxacin, Dichloroflurobenzene, Naproxen, Benzimadizole. The Company’s API’s products include Pantoprazole Sodium Sesquihydrate USP/BP/EP/IP, Esomeprazole Magnesium Trihydrate-USP/BP/IP/EP, Esomeprazole Magnesium Trihydrate-USP/BP, Esomeprazole Magnesium Dihydrate, Omeprazole Powder-USP / BP/ EP/IP, Omeprazole Magnesium-IP/EP/USP and others. Its intermediates products include 2-Mercapto-5-Methoxy Benzimidazole (Omeprazole-Benzimidazole), 2-Chloro-Methyl-3,5-Dimethyl-4-Methoxy Pyridine HCL (Omeprazole Chloro Compound), Ammonium Sulphate, Sodium Nitrite and others. Its products under development include Sitagliptin, Vildagliptin, Ilaprazole, N-(5-Amino-2-Methylphenyl)-4-(3-Pyridyl)-2-Pyrimidineamine (Imatinib Intermediate), Lanso Sulphide and others. ;

STOCK SUMMARY • Face Value (₹) 10.00 • Beta 0.21 • 52-Week Low (₹) 95.00 • 52-Week High (₹) 165.00 • Price-to-Book (X)* 1.76 • Dividend Yield (%) 0.00 • Price-to-Earnings (P/E) (X)* 0.00 • Earnings Per Share (₹) 0.00 • Sector Price Earning (X)* 29.86 • Market Cap (₹ Cr.)* 81.26 • * Vaues as of last close price COMPETITORS • Glaxosmithkline Pharmaceuticals ₹1,412.20 16.20 (1.16%) • Laurus Labs ₹359.00 -1.10 (0.31%) • Lupin ₹818.75 1.30 (0.16%) • Syngene International ₹743.50 4.70 (0.64%) • Alkem Laboratories ₹3,372.85 -16.60 (0.49%) • Dr Reddys Laboratories ₹4,699.00 -3.00 (0.06%) • Aurobindo Pharma ₹669.75 -11.85 (-1.74%) The peers of Everest Organics Ltd are Glaxosmithkline Pharmaceuticals Ltd, Laurus Labs Ltd, Lupin Ltd, Syngene International Ltd, Alkem Laboratories Ltd, Dr Reddys Laboratories Ltd, Aurobindo Pharma Ltd, Torrent Pharmaceuticals Ltd, Ajanta Pharma Ltd, Sun Pharmaceuticals Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Zydus Lifesciences Ltd, Biocon Ltd. Everest Organics Ltd, incorporated in the year 1993, has its registered office in Aroor Village, Sadasivpet Mandal, Medak, Telangana, 502291, 91-8455-250113, 91-8455-250114. The main industry in which Everest Organics Ltd operates is Pharmaceuticals - Indian - Bulk Drugs. Auditor/Auditors for Everest Organics Ltd is/are Suryam & Co/P S N Ravishanker & Associates. In the main management, K. Ramakrishnam Raju is chairman and Rekha Singh is the company secretary for Everest Organics Ltd. • SKHK S K Hari Kr...

Everest Organics Ltd. is a Public Limited Listed company incorporated on 19/02/1993 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24230TG1993PLC015426 and registration number is 015426. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 200.05 Cr. and Equity Capital is Rs. 8.00 Cr. for the Year ended 31/03/2022.